NEIL GARRY ARTHUR 🟢 acquired 26.0K shares (1 derivative) of Celldex Therapeutics, Inc. (CLDX) at $34.09 Transaction Date: Jun 25, 2026 | Filing ID: 000008
Director WENSINGER JEREMY C 🟡 adjusted position in 6.7K shares (1 derivative) of V2X, Inc. (VVX) at $74.56 Transaction Date: Jun 25, 2026 | Filing ID: 000008
Director SPIEGELMAN DANIEL K 🟢 acquired 6.0K shares (1 derivative) of vTv Therapeutics Inc. (VTVT) at $35.08 Transaction Date: Jun 26, 2026 | Filing ID: 000006